Inovalon Results Presentation Deck

Continuous Enhancement & Platform Innovation II inovalon Not all platform capabilities have been advanced in their cloud-sophistication as rapidly as others. During the quarter, one of the Company's long-standing platform capabilities, CARA®, a retrospective risk score accuracy platform, experienced an accelerated change in the way clients are looking to purchase its capabilities. Working with clients, the Company implemented an accelerated advancement of the platform to take greater advantage of the Company's cloud capabilities, enable greater modularity, higher client value creation, and greater platform offering efficiencies. While generating a revenue impact and introducing a short-term cost impact from the accelerated development, this conversion is being well received by existing and potential clients and bodes well for us in the medium and longer term. Early 2000s HEDIS Advantage™ CARAⓇ OSI Star Advantage Prospective Advantage HI QSHR OSCLE 9 INDICES Data Diagnostics™ QSI-XLTH Quality Spectrum™ Policy 380Ⓒ Slide Graphic for illustrative purposes only. Not all platform capabilities are shown. Underlying technologies (IPORT, PASS, PCIS, etc.) not displayed. INOV 02 2016 Eamings Presentation Supplement (8.3.16) v1.0.0 EHR Interoperability asI-XL THE CCA INDICES CCA Star Advantage CCA PAC Platform Current Life Sciences Stack CARAⓇ CCA Prospective Advantage CCA © 2016 by Inovalon. All rights reserved.

View entire presentation